Novelion Therapeutics Announces Filing of Definitive Proxy Statement in Connection with Proposed Liquidation and Other Matters Oct 3, 2019 06:21PM
Novelion Therapeutics Announces Filing of Definitive Proxy Statement in Connection with Proposed Liquidation and Other Matters Oct 3, 2019 06:21PM
Novelion Therapeutics Announces Completion of Aegerion Transaction and Departure of Certain Directors and Officers Sep 25, 2019 08:25AM
Novelion Therapeutics Announces Completion of Aegerion Transaction and Departure of Certain Directors and Officers Sep 25, 2019 08:25AM
Novelion Therapeutics Announces US Court Confirmation of Aegerion Bankruptcy Case, Update on Nasdaq Delisting and Date of Annual General Meeting of Shareholders Sep 11, 2019 05:50PM


Sep 11, 2019 05:50PM Novelion Therapeutics Announces US Court Confirmation of Aegerion Bankruptcy Case, Update on Nasdaq Delisting and Date of Annual General Meeting of Shareholders
Aug 30, 2019 08:02AM Novelion Therapeutics Provides Update Regarding Delisting from Nasdaq and Aegerion Bankruptcy Case
Aug 30, 2019 08:02AM Novelion Therapeutics Provides Update Regarding Delisting from Nasdaq and Aegerion Bankruptcy Case
Aug 21, 2019 05:09PM Novelion Therapeutics Announces Issuance of General Cease Trade Order in Canada and Notice of Delisting from Nasdaq
Aug 21, 2019 05:09PM Novelion Therapeutics Announces Issuance of General Cease Trade Order in Canada and Notice of Delisting from Nasdaq
Aug 12, 2019 04:34PM Novelion Therapeutics Announces Anticipated Late Filing of Quarterly Report on Form 10-Q for the Quarter Ended June 30, 2019
Aug 12, 2019 04:34PM Novelion Therapeutics Announces Anticipated Late Filing of Quarterly Report on Form 10-Q for the Quarter Ended June 30, 2019
Jul 16, 2019 06:43PM Novelion Therapeutics Announces Dismissal of Whitefort Capital Petition
Jul 16, 2019 06:43PM Novelion Therapeutics Announces Dismissal of Whitefort Capital Petition
Jul 5, 2019 08:35AM Novelion Therapeutics (NVLN) Receives Delisting Notifications from Nasdaq
Jul 5, 2019 08:30AM Novelion Therapeutics Receives Delisting Notifications
Jul 5, 2019 08:30AM Novelion Therapeutics Receives Delisting Notifications
Jun 24, 2019 08:35AM Novelion Therapeutics (NVLN) Releases Statement Responding to Whitefort Capital Petition
Jun 24, 2019 08:30AM Novelion Therapeutics Responds to Whitefort Capital Petition
Jun 24, 2019 08:30AM Novelion Therapeutics Responds to Whitefort Capital Petition
May 21, 2019 06:05AM Novelion Therapeutics (NVLN) Unit Aegerion to Recapitalize Through Court Supervised Process
May 20, 2019 10:53PM Novelion Therapeutics Announces Subsidiary Aegerion Pharmaceuticals to Recapitalize Through Court Supervised Process In Which Amryt Pharma Plc Will Acquire 100% of Reorganized Stock of Aegerion
May 20, 2019 10:53PM Novelion Therapeutics Announces Subsidiary Aegerion Pharmaceuticals to Recapitalize Through Court Supervised Process In Which Amryt Pharma Plc Will Acquire 100% of Reorganized Stock of Aegerion
May 7, 2019 04:01PM Novelion Therapeutics Reports First Quarter 2019 Financial Results
May 7, 2019 04:01PM Novelion Therapeutics Reports First Quarter 2019 Financial Results
Mar 14, 2019 05:12PM Novelion Therapeutics Reports Fourth Quarter and Full Year 2018 Financial Results
Mar 14, 2019 05:12PM Novelion Therapeutics Reports Fourth Quarter and Full Year 2018 Financial Results
Feb 6, 2019 05:57AM Novelion Therapeutics (NVLN) Subsidiary Aegerion Pharmaceuticals, Inc. Signs Licensing Agreement with Recordati Rare Diseases Inc. for JUXTAPID in Japan
Feb 6, 2019 02:30AM Novelion Therapeutics Subsidiary Enters Into Licensing Agreement for JUXTAPID® in Japan
Feb 6, 2019 02:30AM Novelion Therapeutics Subsidiary Enters Into Licensing Agreement for JUXTAPID® in Japan
Nov 20, 2018 04:05PM Novelion Therapeutics Announces Leadership Change
Nov 20, 2018 04:05PM Novelion Therapeutics Announces Leadership Change
Nov 9, 2018 08:46AM Novelion Therapeutics Reports Third Quarter 2018 Financial Results
Nov 9, 2018 08:46AM Novelion Therapeutics Reports Third Quarter 2018 Financial Results
Nov 8, 2018 08:48AM Novelion Therapeutics Subsidiary Enters Into Term Loan Agreement and Novelion Provides Business Update
Nov 8, 2018 08:48AM Novelion Therapeutics Subsidiary Enters Into Term Loan Agreement and Novelion Provides Business Update